THERAVECTYS
Theravectys is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.
THERAVECTYS
Industry:
Biopharma Biotechnology Health Care
Founded:
2005-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.theravectys.site
Total Employee:
1+
Status:
Active
Contact:
33 1 44 38 93 13
Total Funding:
40.58 M EUR
Technology used in webpage:
Domain Not Resolving Euro Person Schema Gravatar Profiles UNPKG Leaflet OpenStreetMap
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Grant - Theravectys
Tethys BioScience
Tethys BioScience investment in Series D - Theravectys
Guy PAILLAUD
Guy PAILLAUD investment in Series C - Theravectys
Richard HENNESSY
Richard HENNESSY investment in Series C - Theravectys
Philippe ODDO
Philippe ODDO investment in Series C - Theravectys
John PIETERS
John PIETERS investment in Series C - Theravectys
